Related Experiment Video
Updated: Jan 10, 2026

An Ex Vivo Explant Model for Studying Glial Interactions in the Mouse Retina
Published on: July 15, 2025
Neurological involvement in IgG4-related disease: focus on neuro-ophthalmologic features
Doruk Arslan1,2, Ayse Ilksen Colpak1, Gozde Kubra Yardimci3
1Department of Neurology, School of Medicine, Hacettepe University, Sihhiye, Ankara, Turkey.
Background:
IgG4-related disease (IgG4-RD) is a fibroinflammatory disorder that can affect multiple organs, yet neurological involvement has been considered rare and remains under-characterized.
Methods:
We retrospectively analyzed 77 adult patients with IgG4-RD registered in our database between 2014 and 2023. Clinical, laboratory, imaging, histopathological, and therapeutic data were reviewed, with particular focus on neurological manifestations.
Results:
Neurological involvement was identified in 17 patients (22%), comprising neuro-ophthalmologic disease (n = 10), hypertrophic pachymeningitis (n = 6), and hypophysitis (n = 1). Patients with neurological involvement did not differ in age or sex from overall cohort (mean age 47.5 years; female-to-male ratio 1:1.3). Neuro-ophthalmologic disease was the predominant manifestation, typically presenting with the triad of headache, proptosis, and diplopia. Misdiagnoses such as idiopathic orbital inflammation or Tolosa-Hunt syndrome were frequent. MRI findings included orbital mass effect, optic sheath enhancement, and in some cases intracranial extension. Biopsy confirmed diagnosis in the majority, and histopathological features were indistinguishable from other organ involvements of IgG4-RD. While 60% achieved remission with glucocorticoids alone, the remainder required rituximab due to resistance or relapse. Notably, patients with neurological involvement were diagnosed earlier than those with extra-neurological disease, reflecting the clinical impact of neurological symptoms.
Conclusion:
Neurological involvement in IgG4-RD may be more common than previously recognized, with neuro-ophthalmologic disease emerging as the leading phenotype. The symptom triad of headache, proptosis, and diplopia should prompt consideration of IgG4-RD in patients with orbital disease. Early recognition and timely immunosuppressive therapy are crucial to improving outcomes, and prospective studies are warranted to further delineate the neurological spectrum of this condition.
More Related Videos
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...